You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PCR Conversion

Showing 1 - 25 of 2,778
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Sars-CoV2 Trial in Manhasset, New Hyde Park (COVID-19 PCR and Serology)

Completed
  • Sars-CoV2
  • COVID-19 PCR and Serology
  • Manhasset, New York
  • +1 more
Nov 4, 2021

SARS-CoV-2 Infection Trial in Hohhot (Azvudine, Paxlovid group)

Recruiting
  • SARS-CoV-2 Infection
  • Hohhot, Inner Mongolia, China
    Hohhot First Hospital
Dec 7, 2022

COVID-19 Serologic and Virologic Testing to Accelerate Recovery

Withdrawn
  • Covid19
  • SARS-CoV Infection
    • Lexington, Kentucky
      University of Kentucky
    Sep 9, 2022

    Unresectable Lung Non-Small Cell Carcinoma Trial (serplulimab plus chemo as conversion treatment)

    Not yet recruiting
    • Unresectable Lung Non-Small Cell Carcinoma
    • serplulimab plus chemotherapy as conversion treatment
    • (no location specified)
    Apr 27, 2023

    COVID-19 Trial in Makassar (Vitamin D3 10000 IU, Vitamin D3 1000 IU)

    Completed
    • COVID-19
    • Vitamin D3 10000 IU
    • Vitamin D3 1000 IU
    • Makassar, South Sulawesi, Indonesia
      Wahidin Sudirohusodo General Hospital
    Nov 17, 2021

    COVID-19 Trial in Jakarta Pusat, Jakarta, Depok (biological, other, drug)

    Completed
    • COVID-19
    • Injection of secretome - mesenchymal stem cell
    • +2 more
    • Jakarta Pusat, DKI Jakarta, Indonesia
    • +3 more
    Nov 13, 2021

    Gastric Cancer Trial (Envolimab, Fuquinitinib, Oxaliplatin)

    Not yet recruiting
    • Gastric Cancer
    • (no location specified)
    Jun 13, 2023

    Gastric Cancer Trial in Tianjin (AK104, Apatinib, Paclitaxel)

    Recruiting
    • Gastric Cancer
    • Tianjin, China
      Tianjin Medical University Cancer Institute and Hospital
    May 7, 2023

    Squamous Cell Carcinoma of Head and Neck Trial in Hangzhou (Toripalimab)

    Recruiting
    • Squamous Cell Carcinoma of Head and Neck
    • Hangzhou, Zhejiang, China
      Department of Medical Onocology, First Affiliated Hospital of Zh
    Oct 7, 2023

    Esophageal Squamous Cell Carcinoma, Locally Advanced Carcinoma Trial in Nanjing (Tislelizumab, 5-FU, cis Platinum)

    Recruiting
    • Esophageal Squamous Cell Carcinoma
    • Locally Advanced Carcinoma
    • Nanjing, Jiangsu, China
      Jiangsu Provincial People's Hospital
    Jul 19, 2022

    Borderline Resectable Carcinoma, Biliary Tract Cancer Trial in Washington (Durvalumab, Tremelimumab, Gemcitabine)

    Not yet recruiting
    • Borderline Resectable Carcinoma
    • Biliary Tract Cancer
    • Washington, District of Columbia
      Lombardi Comprehensive Cancer Center, Georgetown University
    Aug 24, 2023

    Combined TACE, TKI/Anti-VEGF and ICIs as Conversion Therapy for

    Recruiting
    • Hepatocellular Carcinoma Non-resectable
    • TACE
    • +8 more
    • Quanzhou, Fujian, China
    • +3 more
    Jan 29, 2023

    Hepatocellular Carcinoma Trial in Guangzhou (Liver Resection)

    Recruiting
    • Hepatocellular Carcinoma
    • Liver Resection
    • Guangzhou, Guangdong, China
      Sun Yat-Sen University Cancer Center
    Jul 21, 2022

    Combined HAIC, TKI/Anti-VEGF and ICIs as Conversion Therapy for

    Recruiting
    • Hepatocellular Carcinoma Non-resectable
    • HAIC
    • +8 more
    • Quanzhou, Fujian, China
    • +1 more
    Jan 26, 2023

    Coronavirus Disease 2019 Trial in Shanghai (Huashi Baidu granule, compound pholcodine oral solution)

    Completed
    • Coronavirus Disease 2019
    • Huashi Baidu granule
    • compound pholcodine oral solution
    • Shanghai, Shanghai, China
      Shanghai children's medical center
    Aug 15, 2022

    Esophageal Squamous Cell Carcinoma by AJCC V8 Stage, Unresectable Trial in Tianjin (tislelizumab+ Paclitaxel + Cisplatin)

    Recruiting
    • Esophageal Squamous Cell Carcinoma by AJCC V8 Stage
    • Unresectable
    • tislelizumab+ Paclitaxel + Cisplatin
    • Tianjin, Tianjin, China
      Hongjing Jiang
    Jul 7, 2022

    Gastric Cancer Trial in Zhengzhou (fruquintinib + sintilimab + SOX)

    Not yet recruiting
    • Gastric Cancer
    • fruquintinib + sintilimab + SOX
    • Zhengzhou, Henan, China
    • +1 more
    Dec 15, 2021

    Gene Expression Of Suppressor Of Cytokines in In Cutaneous Warts

    Not yet recruiting
    • Warts
    • Detection of expression of SOCS3 gene
    • +2 more
    • (no location specified)
    Mar 12, 2023

    Edentulous Maxilla Trial in Pune (CAD-CAM fabricated provisional prosthesis, DC (denture conversion) provisional prosthesis)

    Not yet recruiting
    • Edentulous Maxilla
    • CAD-CAM fabricated provisional prosthesis
    • DC (denture conversion) provisional prosthesis
    • Pune, India
      M.A. Rangoonwala College of Dental Sciences and Research Center,
    Apr 10, 2022

    Tobacco and Nicotine Consumption and Risk of Acquisition of

    Completed
    • COVID-19
    • questionnaire
    • Paris, France
      Hotel-Dieu Hospital
    Nov 19, 2021

    Influenza Trial in Baltimore, Durham (Influenza RG-A/Texas/71/2017 (H3N2) Challenge, Placebo)

    Recruiting
    • Influenza
    • Influenza RG-A/Texas/71/2017 (H3N2) Challenge
    • Placebo
    • Baltimore, Maryland
    • +1 more
    Aug 4, 2022

    MDD Trial (Low Dose 5-hydroxytryptophan, High Dose 5-hydroxytryptophan, Low Dose Creatine Monohydrate)

    Not yet recruiting
    • Major Depressive Disorder
    • Low Dose 5-hydroxytryptophan
    • +4 more
    • (no location specified)
    Jun 8, 2023

    Adebrelimab, Hepatocellular Carcinoma, Transformation Trial in Xiamen (TACE with adebrelimab and bevacizumab)

    Not yet recruiting
    • Adebrelimab
    • +4 more
    • TACE with adebrelimab and bevacizumab
    • Xiamen, Fujian, China
      The First Affiliated Hospital of Xiamen University
    Jul 25, 2023

    Reservoir in Individuals Controlling HIV Infection

    Not yet recruiting
    • Hiv
      • (no location specified)
      Aug 23, 2023

      Corona Virus Infection Trial (Assisting to the event)

      Withdrawn
      • Corona Virus Infection
      • Assisting to the event
      • (no location specified)
      Dec 10, 2021